America’s Cell and Gene Therapy CDMOs Are Scaling at Breakneck Speed!

The Capacity Race Has Begun Digital Intelligence Enters the Cleanroom Partnerships Shape the Competitive Landscape Early-Stage Science Fuels Market Leadership Cell Therapy Takes the Lead Oncology Leads, Rare Diseases Accelerate A Global Surge Mirrors U.S. Momentum The Industry Is Moving From Innovation to Industrialization